At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 130 enrolled
Drug / intervention
Permethrin Foam 4% +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison Study of the Safety and Efficacy of Permethrin Foam, 5% Versus Permethrin Foam, 4% Versus Vehicle in Subjects With Sarcoptes Scabiei
In Brief
A Phase 2 clinical trial evaluating Permethrin Foam 4%, Permethrin Foam 5%, and 1 other intervention for Scabies. Completed, enrolled 130 participants across 9 sites in 4 countries.
Detailed Summary
To determine and compare the safety and efficacy of permethrin foam 4% and permethrin foam 5% with that of vehicle in subjects with scabies.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScabies
CountriesDominican Republic, Honduras, Puerto Rico, United States
CollaboratorsDPT Laboratories, Ltd., Vyne Therapeutics Inc.
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 2014
Enrollment StartApr 2014
Primary CompletionDec 2014
TodayJul 2026
First PostedMar 24, 2014
Enrollment StartApr 1, 2014
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 12.3 years ago
Interventions
Permethrin Foam 4%drug
Topical application, whole-body treatment
Permethrin Foam 5%drug
Topical application, whole-body treatment
Vehicle Foamdrug
Topical application, whole-body treatment